GW4 AMR Alliance Launch Event

June 16, 2021

The aim of the interdisciplinary GW4 AMR Alliance is to become the UK’s leading ‘One Health’ AMR research consortium, recognised globally.  We will increase understanding of, and develop and implement effective interventions for, containing and controlling AMR.

The GW4 AMR Alliance online launch event – ‘GW4 AMR Alliance: Our Interdisciplinary Approach to One Health AMR’ is taking place on Wednesday 16 June 2021 (13:30-17:00). It will comprise a showcase of our One Health AMR research with Q&A and roundtable discussion sessions.

To register, please go to the Eventbrite site


Welcome and introduction – ‘The GW4 AMR Alliance’ – Prof Jonathan Knight (University of Bath and Chair of the GW4 Board)

Session 1 – Keynote presentation by Dr Timothy Jinks (Head, Drug-Resistant Infections Programme, Wellcome Trust)

Session 2 – ‘What are drivers of AMR in the One Health Domain?’ (Moderated by Dr Susanne Gebhard, University of Bath)

Short talks by:

  • Prof Matthew Avison (Bristol) ‘One Health Drivers of AMR: lessons from research in the UK and Thailand’
  • Prof Helen Lambert (Bristol) ‘Social and cultural drivers and strategies to reduce the burden of antimicrobial resistance’
  • Prof William Gaze (Exeter) ‘The environmental dimensions of AMR’
  • Prof Jean-Yves Maillard (Cardiff) Biocides: Emergence of microbial resistance and cross-resistance to antimicrobial in the One Health context’
  • Prof Ed Feil (Bath) ‘Gauging the risk from environmental reservoirs of AMR’
  • Prof Stephen Hinchliffe (Exeter) ‘Changing agriculture: Social and economic drivers of disease and treatment decisions in food production settings’
  • Dr Kristen Reyher (Bristol) ‘Veterinary medicine use and One Health AMR – known unknowns’

Q&A and roundtable discussion on future implications for modifying the drivers of AMR (Chaired by Dr Tim Jinks)

Session 3 – The challenge of antimicrobial resistant pathogens in the real world and potential interventions

Short talks by:

  • Dr Maisem Laabei (Bath) ‘A new GW4 early career AMR community to develop leads to treat multi-resistant pathogens’
  • Prof Adilia Warris (MRC Centre for Medical Mycology, Exeter) ‘Challenges of antifungal resistance in clinical practice’
  • Prof Eshwar Mahenthiralingam (Cardiff) ‘AMR lung infections in people with cystic fibrosis and antibiotic treatment failure’

Q&A and roundtable discussion on the next big questions in One Health and the agenda going forwards'(Chaired by Prof Matthew Avison)

Closing remarks – Prof Philip Taylor (University of Bristol and GW4 Board)